Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Retractable TechnologiesRVP 39 EV-to-OCF is 2.07 as of Aug. 10, 2026, which is 92% above its 10-year median of 1.08. GuruFocus rates RVP with a GF Score™ of 39/100 and a GF Value™ of $0.75 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Retractable Technologies ranks better than 57.21% on this metric.
The historical rank and industry rank for Retractable Technologies's EV-to-OCF or its related term are showing as below:
RVP'
s EV-to-OCF Range Over the Past 10 Years
Min: -58.82 Med: 1.08 Max: 118.88
Current: 2.07
During the past 13 years, the highest EV-to-OCF of Retractable Technologies was 118.88. The lowest was -58.82. And the median was 1.08.
RVP's EV-to-OCF is ranked better than 57.21% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.85
vs RVP: 2.07
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Retractable Technologies's PE Ratio (TTM) for today is calculated as:
Retractable Technologies's share price for today is $0.67.
Retractable Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.210.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Retractable Technologies EV-to-OCF Related Terms
Retractable Technologies EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Retractable Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's EV-to-OCF falls into.
Retractable Technologies's current Enterprise Value is $-14.42 Mil.
Retractable Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Retractable Technologies (RVP) has a EV-to-OCF of 2.07 as of Aug. 10, 2026. This is 92% above median its historical median of 1.08. According to the industry distribution chart, Retractable Technologies ranks #365 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 42.8%.
Is Retractable Technologies' EV-to-OCF too high?
Retractable Technologies' current EV-to-OCF of 2.07 is 92% above median its 10-year median of 1.08. The Medical Devices & Instruments industry median EV-to-OCF is 7.85. Retractable Technologies' value of 2.07 is 73.6% below this industry median. Based on the distribution chart, Retractable Technologies ranks #365 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Retractable Technologies has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' EV-to-OCF compare to ZJYL and RGNT?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #365 out of 853 companies for EV-to-OCF. This puts Retractable Technologies in the upper half of its industry. The industry median EV-to-OCF is 7.85. Retractable Technologies' value of 2.07 is 73.6% below this benchmark. While the company's 10-year median is 1.08 vs. the industry median of 7.85, Retractable Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.85, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Retractable Technologies's current EV-to-OCF of 2.07 is 73.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current EV-to-OCF is 2.07, which is 92% above median its own 10-year median of 1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.75, compared to a current price of $0.67 — trading 10.7% below its estimated fair value. The current EV-to-OCF is 2.07, which is 92% above median its 10-year median of 1.08 and 73.6% below the Medical Devices & Instruments industry median of 7.85. Retractable Technologies' overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Retractable Technologies (RVP), the current EV-to-OCF is 2.07 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Retractable Technologies (RVP) Overvalued in 2026?
Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued.
The current stock price of $0.67 is trading 10.7% below its estimated GF Value™ of $0.75.
GuruFocus considers Retractable Technologies to be Modestly Undervalued.
Key valuation signals for RVP:
EV-to-OCF: 2.07 (92% above median its 10-year median of 1.08)
GF Value™: $0.75 vs. price of $0.67 (10.7% below fair value)
Industry Position: 73.6% below the Medical Devices & Instruments median (#365 of 853)
No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
39GF Score
Get the complete analysis for RVP
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVP has been successfully added to your 
